The export market share of the pharmaceutical industry in Chile is forecasted to remain consistent at 0.026 from 2024 to 2028. The data indicates that there will be no year-on-year variation in the market share percentage, suggesting a stable but stagnant market outlook.
In 2023, the actual export market share also stood at 0.026, indicating that the industry has reached a plateau with no observed growth in recent years. Consequently, the compound annual growth rate (CAGR) over the last five years is 0%, further highlighting the market’s stability.
Future trends to watch for:
• Potential governmental policies impacting pharmaceutical exports.
• Innovations and technological advancements in pharmaceutical manufacturing.
• Global market dynamics affecting demand for Chilean pharmaceutical products.
• Competitive dynamics within the Latin American pharmaceutical industry.
